Genetic heterogeneity in acute myeloid leukemia: Maximizing information flow from MuLV mutagenesis studies

Leukemia

Volumn 14, Issue 7, 2000, Pages 1174-1184

  Largaespada, D A ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Acute myeloid leukemia; Molecular cloning; Mouse; MuLV

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL DEATH; CELL GROWTH; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; GENE MUTATION; GENETIC HETEROGENEITY; HEMATOPOIETIC STEM CELL; MOUSE; MURINE LEUKEMIA VIRUS; MUTAGENESIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; TRANSGENE; VIRUS ISOLATION;

EID: 0033920886     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401852     Document Type: Review

References (94)

1. Lohuizen Mv, Berns A. Tumorigenesis by slow transforming retroviruses - an update. Biochim Biophys Acta 1990; 1032: 213-235.
2. Tsichlis PN, Lazo PA. Virus-host interactions and the pathogenesis of murine and human oncogenic retroviruses. Curr Top Microbiol Immunol 1991; 171: 95-171.
3. Kung HJ, Boerkoel C, Carter TH. Retroviral mutagenesis of cellular oncogenes: a review with insights into the mechanisms of insertional activation. Curr Top Microbiol Immunol 1991; 171: 1-25.
4. Athas GB, Starkey CR, Levy LS. Retroviral determinants of leukemogenesis. Crit Rev Oncog 1994; 5: 169-199.
5. Jonkers J, Berns A. Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochim Biophys Acta 1996; 1287: 29-57.
6. Fan H. Leukemogenesis by Moloney murine leukemia virus: a multistep process. Trends Microbiol 1997; 5: 74-82.
7. Perkins AS. The pathology of murine myelogenous leukemias. Curr Top Microbiol Immunol 1989; 149: 3-21.
8. Wolff L. Contribution of oncogenes and tumor suppressor genes to myeloid leukemia. Biochim Biophys Acta 1997; 1332: F67-104.
9. Copeland NG, Jenkins NA. Myeloid leukemia: disease genes and mouse models. Prog Exp Tumor Res 1999; 35: 53-63.
10. Gross L. Myeloid leukmeia in thymectomized mice. Proc Soc Exp Biol Med 1960; 103: 509-514.
11. Boiron M, Levy JP, Lasneret J, Oppenheim S, Bernard J. Pathogenesis of Rauscher leukemia. J Natl Cancer Inst 1965; 35: 865-884.
12. Siegler R, Rich MA. Pathogenesis of virus-induced myeloid leukemia in mice. J Natl Cancer Inst 1967; 38: 31-50.
13. McGarry MP, Steeves RA, Eckner RJ, Mirand EA, Trudel PJ. Isolation of a myelogenous leukemia-inducing virus from mice infected with the Friend virus complex. Int J Cancer 1974; 13: 867-878.
14. Bryant ML, Scott JL, Pal BK, Estes JD, Gardner MB. Immunopathology of natural and experimental lymphomas induced by wild mouse leukemia virus. Am J Pathol 1981; 104: 272-282.
15. Fredrickson TN, Langdon WY, Hoffman PM, Hartley JW, Morse HC. Histologic and cell surface antigen studies of hematopoietic tumors induced by Cas-Br-M murine leukemia virus. J Natl Cancer Inst 1984; 72: 447-454.
16. Bedigian HG, Johnson DA, Jenkins NA, Copeland NG, Evans R. Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH-2 mice. J Virol 1984; 51: 586-594.
17. Mucenski ML, Taylor BA, Jenkins NA, Copeland NG. AKXD recombinant inbred strains: models for studying the molecular genetic basis of murine lymphomas. Mol Cell Biol 1986; 6: 4236-4243.
18. Silver JE, Fredrickson TN. Susceptibility to Friend helper virus leukemias in CXB recombinant inbred mice. J Exp Med 1983; 158: 1693-1702.
19. Ichikawa Y, Maeda M, Horuichi M. In vitro differentiation of Rauscher-virus-induced myeloid leukemia cells. Int J Cancer 1976; 17: 789-797.
20. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451-458.
21. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 460-462.
22. Lavau C, Dejean A. The t(15;17) translocation in acute promyelocytic leukemia. Leukemia 1994; 8 (Suppl. 2): S9-S15.
23. Chen S-J, Wang Z-Y, Chen Z. Acute promyelocytic leukemia: from clinic to molecular biology. Stem Cells 1995; 13: 22-31.
24. Bundy LM, Ru M, Zheng BF, Gheng L, Pattengale PK, Portis JL, Fan H. Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China. Virology 1995; 212: 367-82.
25. Brown D, Kogan S, Lagasse E, Weisman I, Alcalay M, Pelicci PG, Atwater S, Bishop IM. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci USA 1997; 94: 2551-2556.
26. Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Blood 1997; 89: 376-387.
27. He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G, Pandolli PP. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci USA 1997; 94: 5302-5307.
28. Pattengale PK. Tumors of the lymphohaematopoietic system. In Turusov V, Mohr U (eds). Pathology of Tumors in Laboratory Animals. IARC Scientific Publications: Lyon, 1994, pp 1034-1056.
29. Largaespada DA, Shaughnessy JD Jr, Jenkins NA, Copeland NG. Retroviral integration at the Evi-2 lotus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels. J Virol 1995; 69: 5095-5102.
30. Mucenski ML, Taylor BA, Ihle IN, Hartley JW, Morse HC, Jenkins NA, Copeland NG. Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Mol Cell Biol 1988; 8: 301-308.
31. Copeland NG, Buchberg AM, Gilbert DJ, Jenkins NA. Recombinant inbred mouse strains: models for studying the molecular genetic basis of myeloid tumorigenesis. Curr Top Microbiol Immunol 1989; 149: 45-57.
32. Li JP, D'Andrea AD, Lodish HF, Baltimore D. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 1990; 343: 762-764.
33. Chesebro B, Portis JL, Wehrly K, Nishio J. Effect of murine host genotype on MCF virus expression, latency, and leukemia cell type of leukemias induced by Friend murine leukemia helper virus. Virology 1983; 128: 221-233.
34. Bedigian HG, Taylor BA, Meier H. Expression of murine leukemia viruses in the highly lymphomatous BXH-2 recombinant inbred mouse strain. J Virol 1981; 39: 632-640.
35. Mucenski ML, Taylor BA, Copeland NG, Jenkins NA. Characterization of somatically acquired ecotropic and mink cell focus-forming viruses in lymphomas of AKXD recombinant inbred mice. J Virol 1987; 61: 2929-2933.
36. Belli B, Wolff L, Nazarov V, Fan H. Proviral activation of the c-myb proto-oncogene is detectable in preleukemic mice infected neonatally with Moloney murine leukemia virus but not in resulting end stage T lymphomas. J Virol 1995; 69: 5138-5141.
37. Mitelman F, Mertens F, Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 1997; 15: 417-474.
38. Johansson B, Mertens F, Mitelman F. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chromosomes Cancer 1993; 8: 205-218.
39. O'Marcaigh AS, Shannon KM. Role of the NF1 gene in leukemo-genesis and myeloid growth control. J Pediatr Hematol Oncol 1997; 19: 551-554.
40. Largaespada DA, Brannan CI, Jenkins NA, Copeland NG. Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia. Nat Genet 1996; 12: 137-143.
41. Nakamura T, Largaespada DA, Shaughnessy JD Jr, Jenkins NA, Copeland NG. Cooperative activation of Hoxa and Pbx1-related genes in murine myploid leukaemias. Nat Genet 1996; 12: 149-153.
42. Nakamura T, Fargaespada DA, Fee MP, Johnson FA, Ohyashiki K, Toyama K, Chen SJ, Willman CF, Chen IM, Feinberg AP, Jenkins NA, Copeland NG, Shaughnessy JD. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat Genet 1996; 12: 154-158.
43. Li J, Shen H, Himmel KL, Dupuy AJ, Largaespada DA, Nakamura T, Shaughnessy JD, Jenkins NA, Copeland NG. Leukaemia disease genes: large-scale cloning and pathway predictions. Nat Genet 1999; 23: 348-353.
44. Look AT. Oncogenic transcription factors in the human acute leukemias. Science 1997; 278: 1059-1064.
45. Johansson B, Mertens F, Mitelman F. Primary vs. secondary neoplasia-associated chromosomal abnormalities - balanced rearrangements vs. genomic imbalances? Genes Chromosomes Cancer 1996; 16: 155-163.
46. Johansson B, Mertens F, Mitelman F. Secondary chromosomal abnormalities in acute leukemias. Leukemia 1994; 8: 953-962.
47. Castilla LH, Garrett L, Adya N, Orlic D, Dutra A, Anderson S, Owens J, Eckhaus M, Bodine D, Liu PP. The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia. Nat Genet 1999; 23: 144-146.
48. Gribble SM, Sinclair PB, Grace C, Green AR, Nacheva EP. Comparative analysis of G-banding, c hromosome painting, locus-specific fluorescence in situ hybridization, and comparative genomic hybridization in chronic myeloid leukemia blast crisis. Cancer Genet Cytogenet 1999; 111: 7-17.
49. Nacheva E, Grace C, Holloway TL, Green AR. Comparative genomic hybridization in acute myeloid leukemia. A comparison with G-banding and chromosome painting. Cancer Genet Cytogenet 1995; 82: 9-16.
50. Bents M, Dohner H, Huck K, Schutz B, Ganser A, Joos S, du Manoir S, Lichter P. Comparative genomic hybridization in the investigation of myeloid leukemias. Genes Chromosomes Cancer 1995; 12: 193-200.
51. Buchberg AM, Bedigian HG, Jenkins NA, Copeland NG. Evi-2, a common integration site involved in murine myeloid leukemogenesis. Mol Cell Biol 1990; 10: 4658-4666.
52. Herr W, Schwartz D, Gilbert W. Isolation and mapping of cDNA hybridization probes specific for ecotropic and nonecotropic murine leukemia proviruses. Virology 1983; 125: 139-154.
53. Jenkins NA, Copeland NG, Taylor BA, Bedigian HG, Lee BK. Ecotropic murine leukemia virus DNA content of normal and lymphomatous tissues of BXH-2 recombinant inbred mice. J Virol 1982; 42: 379-388.
54. Bickmore WA, Bird AP. Use of restriction endonucleases to detect and isolate genes from mammalian cells. Meth Enzymol 1992; 216: 224-244.
55. Cross SH, Bird AP. CpG islands and genes. Curr Opin Genet Dev 1995; 5: 309-314.
56. DePinho RA, Jacks T. A bumper crop of cancer genes. Nat Genet 1999; 23: 255-254.
57. Sorensen AB, Duch M, Amtoft HW, Jorgensen P, Pedersen FS. Sequence tags of provirus integration sites in DNAs of tumors induced by the murine relrovirus SL3-3. J Virol 1996; 70: 4063-4070.
58. Huckaby CS, Kouri RE, Lane MJ, Peshick SM, Carroll WT, Henderson SM, Faldasz BD, Waterbury PG, Vournakis, JN. An efficient technique for obtaining sequences flanking inserted retroviruses. Genet Anal Tech Appl 1991; 8: 151-158.
59. Jorgensen P, Mikkelsen T, Pedersen K, Pedersen FS, Kjeldgaard NO. Tagging the genome of the murine leukemia retrovirus SL3-3 by a bacterial lac operator sequence. Gene 1991; 109: 243-247.
60. Denicourt C, Edouard E, Rassart E. Oncogene activation in myeloid leukemias by Graifi murine leukemia virus proviral integration. J Virol 1999; 73: 4439-4442.
61. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meisla but not Pbx1b. EMBO J 1998; 17: 3714-3725.
62. Lawrence HJ, Rozenfeld S, Cruz C, Matsukuma K, Kwong A, Komuves L, Buchberg AM, Largman C. Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias. Leukemia 1999; 13: 1993-1999.
63. Mercader N, Leonardo E, Azpiazu N et al. Conserved regulation of proximodistal limb axis development by Meis1/Hth. Nature 1999; 402: 425-429.
64. Shen WF, Rozenfeld S, Kwong A, Kom ves LG, Lawrence HJ, Largman C. HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. Mol Cell Biol 1999; 19: 3051-3061.
65. van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, Berns A. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 1991; 65: 717-752.
66. Neil J, Stewart M, Terry A et al. Identification of murine CBF alpha1, a runt domain transcription factor, as a putative Myc collaborator in T cell lymphoma. Leukemia 1999; 13 (Suppl. 11: S83-S86.
67. Traver D, Akashi K, Weissman IL, Lagasse E. Mice detective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity 1998; 9: 47-57.
68. Grisolano JL, Sclar GM, Lev TJ. Early myeloid cell-specific expression of the human cathepsin G gene in transgenic mice. Proc Natl Acad Sci USA 1994; 91: 8989-8993.
69. Greer P, Maltby V, Rossant J, Bernstein A, Pawson T. Myeloid expression of the human c-fps/fes proto-oncogene in transgenic mice. Mol Cell Biol 1990; 10: 2521-2527.
70. Honda H, Oda H, Suzuki T et al. Development of acute lymphoblastic leukemia and myeloproliferalive disorder in transgenic mice expressing p210bcr/abl: a novel transgenic model for human Ph1-positive leukemias. Blood 1998; 91: 2067-2075.
71. You Y, Browning VL, Schimenti JC. Generation of radiation-induced deletion complexes in the mouse genome using embryonic stem cells. Methods 1997; 13: 409-421.
72. Zheng B, Sage M, Sheppard EA, Jurecic V, Bradley A. Engineering mouse chromosomes with cre-loxP: range, efficiency, and somatic applications. Mol Cell Biol 2000; 20: 648-655.
73. O'Brien SJ, Menotti-Raymond M, Murphy WJ et al. The promise of comparative genomics in mammals. Science 1999; 286: 458-462.
74. Fan H, Mittal S, Chute H, Chao E, Pattengale PK. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro. J Virol 1986; 60: 204-214.
75. Ru M, Shustik C, Rassart E, Graffi murine leukemia virus: molecular cloning and characterization of the myeloid leukemia-inducing agent. J Virol 1993; 67: 4722-4731.
76. Shen-Ong GL, Wolff L. Moloney murine leukemia virus-induced myeloid tumors in adult BALB/c mice: requirement of c-myb activation but lack of v-abl involvement. J Virol 1987; 61: 3721-3725.
77. Rassart E, Houde J, Denicourt C, Ru M, Barat C, Edouard E, Poliquin L, Bergeron D. Molecular analysis and characterization of two myeloid leukemia inducing murine retroviruses. Curr Top Microbiol Immunol 1996; 211: 201-210.
78. Silver J, Buckler CE. A preferred region for integration of Friend murine leukemia virus in hematopoietic neoplasms is closely linked to the Int-2 oncogene. J Virol 1986; 60: 1156-1158.
79. Bergeron D, Poliquin L, Kozak CA, Rassart E. Identification of a common viral integration region in Cas-Br-E murine leukemia virus-induced non-T-, non-B-cell lymphomas. J Virol 1991; 65: 7-15.
80. Bergeron D, Poliquin L, Houde J, Barbeau B, Rassart E. Analysis of proviruses integrated in Fli-1 and Evi-1 regions in Cas-Br-F MuLV-induced non-T-, non-B-cell leukemias. Virology 1992; 191: 661-669.
81. Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG, Ihle JN. Retroviral activation of a novel gene encoding a zinc finder protein in IL-3-dependent myeloid leukemia cell lines. Cell 1988; 54: 831-840.
82. Bartholomew C, Morishita K, Askew D, Buchberg A, Jenkins NA, Copeland NG, Ihle JN. Retroviral insertions in the CB-1/Fim-3 common site of integration activate expression of the Evi-1 gene. Oncogene 1989; 4: 529-534.
83. Bartholomew C, Ihle JN. Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter. Mol Cell Biol 1991; 11: 1820-1828.
84. Bordereaux D, Fichelson S, Sola B, Tambourin PE, Gisselbrecht S. Frequent involvement of the fim-3 region in Friend murine leukemia virus-induced mouse myeloblastic leukemias. J Virol 1987; 61: 4043-4045.
85. Moskow JJ, Bullrich F, Huebner K, Daar IO, Buchberg AM. Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice. Mol Cell Biol 1995; 15: 5434-5443.
86. Nazarov V, Wolff L. Novel integration sites at the distal 3′ end of the c-myb locus in retrovirus-induced promonocytic leukemias. J Virol 1995; 69: 3885-3888.
87. Wolff L, Koller R, Davidson W. Acute myeloid leukemia induction by amphotropic murine retrovirus (4070A): clonal integrations involve c-myb in some but not all leukemias. J Virol 1991; 65: 3607-3616.
88. Lammie GA, Smith R, Silver J, Brookes S, Dickson C, Peters G. Proviral insertions near cyclin D1 in mouse lymphomas: a parallel for BCL1 translocations in human B-cell neoplasms. Oncogene 1992; 7: 2381-2387.
89. Gisselbrecht S, Fichelson S, Sola B, Bordereaux D, Hampe A, Andre C, Galibert F, Tambourin P. Frequent c-fms activation by proviral insertion in mouse myeloblastic leukaemias. Nature 1987;329 : 259-261.
90. Valk PJ, Hol S, Vankan Y, Ihle JN, Askew D, Jenkins NA, Gilbert DJ, Copeland NG, de Both NJ, Lowenberg B, Delwel R. The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11. J Virol 1997; 71: 6796-6804.
91. Valk PJ, Vankan Y, Joosten M, Jenkins NA, Copeland NG, Lowenberg B, Delwel R. Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincide with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2. J Virol 1999; 73: 3595-3602.
92. Askew DS, Bartholomew C, Buchberg AM, Valentine MB, Jenkins NA, Copeland NG, Ihle JN. His-1 and His-2: identification and chromosomal mapping of two commonly rearranged sites of viral integration in myeloid leukemia. Oncogene 1991; 6: 2041-2047.
93. Askew DS, Li J, Ihle JN. Retroviral insertions in the murine His-1 locus activate the expression of a novel RNA that lacks an extensive open reading frame. Mol Cell Biol 1994; 14: 1743-1751.
94. Shaughnessy JD Jr, Largaespada DA, Tian E, Fletcher CF, Cho BC, Vyas P, jenkins NA, Copeland NG. Mrvi1, a common MRV integration site in BXH-2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jaw1. Oncogene 1999; 18: 2069-2084.